Rituximab as an effective treatment of hyperhemolysis syndrome in sickle cell anemia

被引：42

作者：

Bachmeyer, Claude ^{[1
]}

Maury, Jacqueline

Parrot, Antoine ^{[2
]}

Bachir, Dora ^{[3
]}

Stankovic, Katia ^{[1
,4
]}

Girot, Robert ^{[4
,5
]}

Lionnet, Francois ^{[1
,4
]}

机构：

[1] CHU Tenon, AP HP, Serv Med Interne, Paris, France

[2] CHU Tenon, AP HP, Serv Reanimat Pneumol, Paris, France

[3] CHU Henri Mondor, AP HP, Ctr Reference Drepanocytose, F-94010 Creteil, France

[4] CHU Tenon, AP HP, Ctr Reference Drepanocytose, Paris, France

[5] CHU Tenon, AP HP, Hematol Lab, Paris, France

来源：

AMERICAN JOURNAL OF HEMATOLOGY | 2010年 / 85卷 / 01期

关键词：

DISEASE;

D O I：

10.1002/ajh.21578

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：91 / 92

页数：2

共 6 条

[1] Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions [J].

Aygun, B ;

Padmanabhan, S ;

Paley, C ;

Chandrasekaran, V .

TRANSFUSION, 2002, 42 (01) :37-43

[2] Rituximab for prevention of delayed hemolytic transfusion reaction in sickle cell disease [J].

Noizat-Pirenne, F. ;

Bachir, D. ;

Chadebech, P. ;

Michel, M. ;

Plonquet, A. ;

Lecron, J. -C. ;

Galacteros, F. ;

Bierling, P. .

HAEMATOLOGICA, 2007, 92 (12) :E132-E135

[3] Bystander immune cytolysis [J].

Petz, LD .

TRANSFUSION MEDICINE REVIEWS, 2006, 20 (02) :110-140

[4] Delayed hemolytic transfusion reaction/hyperhemolysis syndrome in children with sickle cell disease [J].

Talano, JAM ;

Hillery, CA ;

Gottschall, JL ;

Baylerian, DM ;

Scott, JP .

PEDIATRICS, 2003, 111 (06) :E661-E665

[5] Drug Insight: the mechanism of action of rituximab in autoimmune disease - the immune complex decoy hypothesis [J].

Taylor, Ronald P. ;

Lindorfer, Margaret A. .

NATURE CLINICAL PRACTICE RHEUMATOLOGY, 2007, 3 (02) :86-95

[6] Hyperhemolysis syndrome in sickle cell disease: case report (recurrent episode) and literature review [J].

Win, Nay ;

New, Helen ;

Lee, Edmond ;

de la Fuente, Josu .

TRANSFUSION, 2008, 48 (06) :1231-1238

← 1 →